Does the Length of Hospital Stay for Rehabilitation Affect Functional Outcomes in Stroke Patients

January 6, 2021 updated by: Betül Çiftçi Tepeli, Baskent University

Does the Length of Hospital Stay for Rehabilitation Affect Functional Outcomes in Stroke Patients: A Retrospective Study

The purpose of this study was to evaluate whether the length of hospital stay for rehabilitation affects functional outcomes of stroke patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The medical records of patients who were admitted to a rehabilitation unit were analyzed retrospectively. The functional output, the level of spasticity, and the level of motor development at admission and discharge will be determined using the Functional Independence Measure instrument, the Modified Ashworth Scale, and the Brunnstrom test, respectively. Based on the length of hospital stay, patients will be divided into two groups: hospital stays ≤ 3 months (Group 1) and > 3 months (Group 2). Clinical features and functional output will be compared between the groups.

Study Type

Observational

Enrollment (Actual)

97

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Kırklareli, Turkey, 39000
        • Kırklareli Univesity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients with a stroke who received rehabilitation in an inpatient clinic between 2010 and 2013

Description

Inclusion Criteria:

  • Clinical diagnosis of stroke
  • must be able to receive rehabilitation in an inpatient clinic between 2010 and 2013

Exclusion Criteria:

  • previous history of stroke,
  • other neurological diseases,
  • amputation,
  • severe arthritis
  • undergoing hemodialysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Based on the length of hospital stay
Based on the length of hospital stay, patients were divided into two groups: hospital stays ≤ 3 months (Group 1) and > 3 months (Group 2).
Other: Based on the length of hospital stay
Based on the length of hospital stay, patients were divided into two groups: hospital stays ≤ 3 months (Group 1) and > 3 months (Group 2).Clinical features and functional output will be then compared between the groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical features and Functional Independence Measure instrument, the Modified Ashworth Scale, and the Brunnstrom test outcomes will be then compared between the groups.
Time Frame: through study completion, an average of 1 month

Demographic features, clinical features and Functional Independence Measure (FIM) instrument, the Modified Ashworth Scale (MAS), and the Brunnstrom test outcomes will be documented for all patients. The FIM includes 18 items with higher scores indicating greater independence. The motor development of the upper extremity, hand, and lower extremity will be evaluated using the Brunnstrom test with higher stages indicating greater development. The degree of spasticity of the upper and lower extremity muscles will be assessed using the MAS with high stage indicating greater spasticity.

All patients will be divided into two groups based on length of hospital stay. Clinical features, demographic features and FIM, MAS, and the Brunnstrom test outcomes will be then compared between the groups. All data for normality were tested with Kolmogorov-Smirnov tests. Mann-Whitney U tests will be used for comparison of the differences between the two groups.
through study completion, an average of 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Baskent University

Investigators

  • Principal Investigator: betül çiftçi tepeli, Kırklareli University School of Health Department of Physical Medicine and Rehabilitiation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2020

Primary Completion (Actual)

November 1, 2020

Study Completion (Actual)

November 1, 2020

Study Registration Dates

First Submitted

December 28, 2020

First Submitted That Met QC Criteria

January 6, 2021

First Posted (Actual)

January 8, 2021

Study Record Updates

Last Update Posted (Actual)

January 8, 2021

Last Update Submitted That Met QC Criteria

January 6, 2021

Last Verified

December 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 94603339-604.01.02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Based on the length of hospital stay

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe